Labetalol pretreatment reduces blood pressure instability during surgical resection of pheochromocytoma

Journal of the Formosan Medical Association

Volumn 105, Issue 3, 2006, Pages 189-193

  Chung, Peter Chi Ho ^a   Ng, Yuet Tong ^a   Hsieh, Jing Ru ^a   Yang, Min Wen ^a   Li, Allen Hon Lun ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Anesthesia; Hypertension; Labetalol; Pheochromocytoma; Sodium nitroprusside

Indexed keywords

ATRACURIUM; FENTANYL; HYPERTENSIVE FACTOR; ISOFLURANE; LABETALOL; NITROPRUSSIDE SODIUM; NITROUS OXIDE PLUS OXYGEN; PHENOXYBENZAMINE; SODIUM CHLORIDE; THIOPENTAL;

ADRENAL MEDULLECTOMY; ADULT; ANESTHESIA INDUCTION; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEART RATE; HUMAN; HYPERTENSION; HYPOTENSION; MALE; MAXIMUM PERMISSIBLE DOSE; PEROPERATIVE COMPLICATION; PHEOCHROMOCYTOMA; PREOPERATIVE TREATMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 33644537399     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60304-1     Document Type: Article

References (19)

1. Farmer JB, Kennedy I, Levy GP, et al. Pharmacology of AH 5158; a drug which blocks both α- and β-adrenoceptors. Br J Pharmacol 1972;45:660-75.
2. Richards DA. Pharmacological effects of labetalol in man. Br J Clin Pharmacol 1976;3(4 Suppl 3):721-3.
3. Brogden RN, Heel RC, Speight TM, et al. Labetalol: a review of its pharmacology and therapeutic use in hypertension. Drugs 1978;15:251-70.
4. Chung PC, Sum DC. Preliminary experience of using fixed dose of intravenous labetalol in surgical resection of pheochromocytoma. Ma Zui Xue Za Zhi 1993;31:211-6.
5. Rosei EA, Brown JJ, Lever AF, et al. Treatment of pheochromocytoma and of clonidine withdrawal hypertension with labetalol. Br J Clin Pharmacol 1976;3:809-17.
6. Tokioka H, Takahashi T, Kosogabe Y, et al. Use of diltiazem to control circulatory fluctuations during resection of a pheochromocytoma. Br J Anaesth 1988;60:582-7.
7. Bailey RR. Labetalol in the treatment of a patient with pheochromocytoma: a case report. Br J Clin Pharmacol 1979;8:141-2.
8. Ueda N, Kitamura Y, Hayashi Y, et al. Anaesthetic management of phaeochromocytoma associated with tricuspid atresia. Can J Anaesth 1991;38:780-4.
9. Fox JM, Manninen PH. The anaesthetic management of a patient with a phaeochromocytoma and acute stroke. Can J Anaesth 1991;38:775-9.
10. Denda S, Sakuma K, Satomi K, et al. Anesthetic management of pheochromocytoma by continuous intravenous injection of prostaglandin E1. Masui 1991;40:972-7. [In Japanese]
11. Kaufman L. Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma. Br J Clin Pharmacol 1979;8(Suppl 2):229S-32S.
12. Allen CT, Imrie D. Hypoglycemia as a complication of removal of a pheochromocytoma. Can Med Assoc J 1977; 116:363-4.
13. Martin R, St-Pierre B, Moliner OR. Phaeochromocytoma and postoperative hypoglycaemia. Can Anaesth Soc J 1979; 26:260-2.
14. Levin H, Heifetz M. Phaeochromocytoma and severe protracted postoperative hypoglycemia. Can J Anaesth 1990:37:477-8.
15. Meeke RI, O'Keeffe JD, Gaffney JD. Pheochromocytoma removal and postoperative hypoglycemia. Anaesthesia 1985;40:1093-6.
16. Tsuji H, Asoh T, Shirasaka C, et al. Inhibition of metabolic responses to surgery with beta-adrenergic blockade. Br J Surg 1980;67:503-5.
17. Day JL. The metabolic consequences of adrenergic blockade: a review. Metabolism 1975;24:987-96.
18. Chung PC, Sum DC. The effect of high dose intravenous labetalol on plasma glucose during surgery. Ma Zui Xue Za Zhi 1993;31:233-6.
19. Orchard T, Grant CS, van Heerden JA, et al. Pheochromocytoma - continuing evolution of surgical therapy. Surgery 1993;114:1153-9.